BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MultiPlan Corporation, Intrusion, Romeo Power, and Acadia Pharmaceuticals and Encourages Investors to Contact the Firm
May 26, 2021 21:00 ET | Bragar Eagel & Squire
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Peloton and ChemoCentryx and Encourages Investors to Contact the Firm
May 26, 2021 21:00 ET | Bragar Eagel & Squire
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Array, ContextLogic, and Ubiquiti and Encourages Investors to Contact the Firm
May 26, 2021 21:00 ET | Bragar Eagel & Squire
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Arcimoto, Churchill, Emergent BioSolutions, and Verus International and Encourages Investors to Contact the Firm
May 26, 2021 21:00 ET | Bragar Eagel & Squire
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FibroGen, Canaan, Credit Suisse, and Franklin Wireless and Encourages Investors to Contact the Firm
May 26, 2021 21:00 ET | Bragar Eagel & Squire
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ebang, 3D Systems, Amdocs, and Champignon Brands and Encourages Investors to Contact the Firm
May 26, 2021 21:00 ET | Bragar Eagel & Squire
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Churchill Capital Corporation IV - CCIV
May 26, 2021 20:50 ET | Pomerantz LLP
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Churchill Capital Corporation IV (“Churchill” or the “Company”) (NYSE: CCIV). Such...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Volkswagen Aktiengesellschaft – VLKAY; VLKPY
May 26, 2021 20:49 ET | Pomerantz LLP
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Volkswagen Aktiengesellschaft (“Volkswagen” or the “Company”) (OTCMKTS:  VLKAY; VLKPY)....
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Emergent BioSolutions Inc. - EBS
May 26, 2021 20:45 ET | Pomerantz LLP
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Emergent BioSolutions Inc. (“Emergent” or the “Company”) (NYSE: EBS). Such investors are...
Reviva Logo.png
Reviva Announces Pricing of Upsized $30 Million Underwritten Public Offering
May 26, 2021 20:43 ET | Reviva Pharmaceuticals
CUPERTINO, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies...